Literature DB >> 35483757

Systematic Review of Physical Activity Trajectories and Mortality in Patients With Coronary Artery Disease.

Nathalia Gonzalez-Jaramillo1, Matthias Wilhelm2, Ana María Arango-Rivas3, Valentina Gonzalez-Jaramillo4, Cristina Mesa-Vieira4, Beatrice Minder5, Oscar H Franco6, Arjola Bano7.   

Abstract

BACKGROUND: The role of lifestyle physical activity (PA) trajectories in the mortality risk of patients with coronary heart disease (CHD) remains unclear.
OBJECTIVES: The purpose of this study was to determine the association of longitudinal PA trajectories with all-cause and cardiovascular disease (CVD) mortality in patients with CHD.
METHODS: Longitudinal cohorts reporting the association of PA trajectories with mortality in patients with CHD were identified in April 2021 by searching 5 databases without language restrictions. Published HRs and 95% CIs were pooled using random effects models and bias assessed by Egger regression.
RESULTS: A total of 9 prospective cohorts included 33,576 patients. The mean age was 62.5 years. The maximum follow-up was 15.7 years. All of the studies assessed PA through validated questionnaires, and mortality was well documented. Changes in PA defined 4 nominal PA trajectories. Compared with always-inactive patients, the risk of all-cause mortality was 50% lower in those who remained active (HR: 0.50; 95% CI: 0.39-0.63); 45% lower in those who were inactive but became active (HR: 0.55; 95% CI: 0.44-0.7); and 20% lower in those who were active but became inactive (HR: 0.80; 95% CI: 0.64-0.99). Similar results were observed for CVD mortality, except for the category of decreased activity (HR: 0.91; 95% CI: 0.67-1.24). The overall risk of bias was low. No evidence of publication bias was found. Multiple sensitivity analyses provided consistent results.
CONCLUSIONS: This study illustrates how patients with CHD may benefit by preserving or adopting an active lifestyle. The observation that the benefits of past activity can be weakened or lost if PA is not maintained may be confounded by disease progression.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary heart disease; lifestyle; mortality; physical activity; survival; trajectories

Mesh:

Year:  2022        PMID: 35483757     DOI: 10.1016/j.jacc.2022.02.036

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  PPBP gene as a biomarker for coronary heart disease risk in postmenopausal Thai women.

Authors:  Chayasin Mansanguan; Yaowapa Maneerat
Journal:  PeerJ       Date:  2022-06-17       Impact factor: 3.061

Review 2.  Effect of Physical Activity/Exercise on Oxidative Stress and Inflammation in Muscle and Vascular Aging.

Authors:  Mariam El Assar; Alejandro Álvarez-Bustos; Patricia Sosa; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

3.  Objectively measured adherence to physical activity among patients with coronary artery disease: Comparison of the 2010 and 2020 World Health Organization guidelines and daily steps.

Authors:  Prisca Eser; Nathalia Gonzalez-Jaramillo; Selina Weber; Jan Fritsche; Riccardo Femiano; Charlotte Werner; Flurina Casanova; Arjola Bano; Oscar H Franco; Matthias Wilhelm
Journal:  Front Cardiovasc Med       Date:  2022-09-28

4.  Feasibility and impact of whole-body high-intensity interval training in patients with stable coronary artery disease: a randomised controlled trial.

Authors:  Jacobina Kristiansen; Tórur Sjúrðarson; Erik Lerkevang Grove; Jan Rasmussen; Steen Dalby Kristensen; Anne-Mette Hvas; Magni Mohr
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

5.  Prognostic impact of physical activity patterns after percutaneous coronary intervention. Protocol for a prospective longitudinal cohort. The PIPAP study.

Authors:  Nathalia Gonzalez-Jaramillo; Prisca Eser; Flurina Casanova; Arjola Bano; Oscar H Franco; Stephan Windecker; Lorenz Räber; Matthias Wilhelm
Journal:  Front Cardiovasc Med       Date:  2022-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.